The future prospects of pharmacogenetics in oral anticoagulation therapy.

Abstract

Coumarins are the mainstay of oral anticoagulation for the treatment and prophylaxis of thromboembolic disorders. They have a narrow therapeutic index and regular monitoring is therefore required to avoid serious adverse effects. There is wide interindividual variability in dosage requirements, which makes anticoagulation response unpredictable. Current… (More)

Topics

  • Presentations referencing similar topics